In a cohort of prostatectomy-treated prostate tumors, four of the DE-lncRNAs showed association with progression-free time, and two of them (lnc-SCFD2-2, and lnc-R3HCC1L-8) were independent prognostic markers. Our study highlights several mCRPC-specific lncRNAs that might be important in the progression of the disease to the metastatic stage and may also serve as potential biomarkers for aggressive PCa.
over 2 years ago
Journal
|
AR (Androgen receptor) • FOXA1 (Forkhead Box A1) • HOXB13 (Homeobox B13) • R3HCC1 (R3H Domain And Coiled-Coil Containing 1) • SCFD2 (Sec1 Family Domain Containing 2)